Authors: Morath C, Weigand MA, Zeier M, Speer C, Tiwari-Heckler S

PMID: 32753056 PMCID: PMC7399583 DOI: 10.1186/s13054-020-03171-3


The spectrum of coronavirus disease 2019 (COVID-19) ranges from asymptomatic infection to respiratory failure and death of patients. Severely affected patients may develop a cytokine storm-like clinical syndrome with multi-organ failure and a mortality rate of up to 90%. Recently, it has been suggested that plasma exchange (PE) may positively influence this unfavorable course.

Keywords: plasma exchange, COVID-19, SARS-CoV-2